Buspirone and lorazepam in the treatment of generalized anxiety disorder in outpatients
✍ Scribed by G. Laakmann; C. Schüle; G. Lorkowski; T. Baghai; K. Kuhn; S. Ehrentraut
- Publisher
- Springer
- Year
- 1998
- Tongue
- English
- Weight
- 442 KB
- Volume
- 136
- Category
- Article
- ISSN
- 0033-3158
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The objective of this study was to investigate the prevalence and timing of sudden gains over the course of brief, psychodynamically oriented treatment for generalized anxiety disorder (GAD). Data were used from two studies of brief (i.e., 16‐session) supportive‐expressive psychotherapy
Ondansetron is a highly selective antagonist at the 5-HT 3 subtype of serotonin (5-HT) receptors . The 5-HT 3 receptors are the only receptors whose effects are mediated through the ion channels rather than the G-protein series . Ondansetron has no appreciable affinity for other 5-HT receptor subtyp
## Abstract Generalized anxiety disorder is a chronic condition characterized by beliefs that worry prepares and protects, but that excessive worry is out of control. In this article, I review the cognitive‐behavioral model of generalized anxiety, focusing specifically on problems related to excess